Trevi Therapeutics, Inc. Common Stock

TRVINASDAQ • USD
13.12 USD
↘ 0.17 (1.28%)🟢LIVE (AS OF 11:54 AM EST)
🟢Market: OPEN

Shares of Trevi Therapeutics, Inc. Common Stock (TRVI) are trading at $13.12. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. TRVI is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$13.61
High?$14.51
Low?$12.83
Prev. Close?$13.29
Volume?449.7K
Avg. Volume?2.3M
VWAP?$13.10
Rel. Volume?0.19x
Bid / Ask
Bid?$13.04 × 600
Ask?$13.08 × 800
Spread?$0.04
Midpoint?$13.06
Valuation & Ratios
Market Cap?1.9B
Shares Out?142.6M
Float?111.4M
Float %?78.2%
P/E Ratio?N/A
P/B Ratio?6.26
EPS?-$0.43
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Employees
34
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2019-05-03
Address
195 CHURCH STREET
NEW HAVEN, CT 06510
Phone: 203-304-2499
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
23
Short Sent.?
14
Piotroski F-Score?0/9Weak
Altman Z-Score?139.79Safe
Confidence?48%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?15.13%High
Short Interest?16.9M
Days to Cover?10.1
Free Float111.4M
Avg Daily Volume1.7M
Settlement Date2026-10-30
Financial Health
Current Ratio?38.86Strong
Quick Ratio?38.86Strong
Cash Ratio?3.54Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
Peers
100
S&P
29
6.26FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-26.7CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
8
-20.1%WEAK▾
ROA?
S&P
3
-19.6%WEAK▾
Cash Flow & Enterprise
FCF?$-61687000
Enterprise Value?$1.9B
Fundamentals ratios updated end of day